Yakult for stronger muscles? study tests probiotic against sarcopenia

NCT ID NCT04985877

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a fermented milk drink containing Lactobacillus casei strain Shirota (sold as Yakult) could improve gut health and slow muscle loss in 132 elderly Taiwanese adults with sarcopenia. Participants drank two bottles daily for 12 weeks. Researchers measured changes in gut bacteria, muscle mass, and strength. The goal was to see if the probiotic could reduce inflammation and support muscle function through the gut-muscle axis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
fermented milk containing Lactobacillus casei strain Shirota (probiotic)
What this could lead to
If it works, this could point toward a simple dietary supplement to help slow muscle loss and improve strength in older adults with sarcopenia.
What could go wrong
This is a small, completed study (132 people) with no blinding or placebo control, so results may be due to chance or other factors. The benefits seen may not apply to other populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Inflammation inflammatory disease Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Taipei Medical University

    Taipei, 110, Taiwan

  • Taipei Medical University Hospital

    Taipei, 110, Taiwan

  • Wanfang Hospital

    Taipei, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.